Home / Companies / Vipamat SAS

Vipamat SAS FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

Latest inspection NAI · Mar 18, 2026
Last warning letter 2011

Inspections 3

1 OAI

Recalls 0 0 Class I

Warning letters 1 Latest May 26, 2011

510(k) clearances 0 None on file

Vipamat SAS has 0 FDA recalls, 3 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Vipamat SAS, the most recent on May 26, 2011.

What these totals cover: FDA records filed under the name "Vipamat SAS" and its spelling variant "Vipamat". Records filed under related names are not included; see Related names.

Latest inspection: Mar 18, 2026 · NAI

Summary

Record counts and when each FDA source was last refreshed
Records	Count	Last refreshed	Source as of	Status
Recalls	0	Nov 8, 2026	File dated Nov 3, 2026	Current
510(k) clearances	0	Nov 8, 2026	File dated Nov 2, 2026	Current
Inspections	3	Nov 14, 2026	Newest record Nov 5, 2026	Current
Compliance actions	1	Nov 2, 2026	Newest record Oct 29, 2026	Current

Reviewing Vipamat SAS as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Vipamat SAS yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Related names

Each name below has its own page. Its counts cover only the records FDA filed under that name and are not part of the totals for Vipamat SAS above.

Name	Relation	Recalls	510(k)	Inspections	Compliance actions	Most recent recall
Vipamat Sarl	Same company group	0	1	0	0	—

Vipamat SAS FDA Warning Letters

1 warning letter on May 26, 2011.

Issued	Subject	Issuing office	Close-out letter
May 26, 2011 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent FDA inspections

3 inspections from Jan 27, 2011 to Mar 18, 2026.

Date	Site	Product	Classification	FEI
Mar 18, 2026	Ploemeur, France	Devices	No Action Indicated (NAI)	3005442882
Dec 4, 2014	Ploemeur, France	Devices	No Action Indicated (NAI)	3005442882
Jan 27, 2011	Ploemeur, France	Devices	Official Action Indicated (OAI)	3005442882

NAI: No objectionable conditions or practices were found during the inspection.
VAI: Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI: Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Vipamat SAS: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, May 26, 2011.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

Facility	Location	Inspections	Latest
FEI 3005442882	Ploemeur, France	3	Mar 18, 2026

Vipamat SAS and the FDA: common questions

Has Vipamat SAS received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Vipamat SAS. The most recent is dated May 26, 2011.

Has Vipamat SAS received an FDA Form 483?

FDA has not published a Form 483 for "Vipamat SAS" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Vipamat SAS?

The most recent FDA inspection on file ended Mar 18, 2026 at Ploemeur, France and was classified NAI. FDA has 3 inspections of Vipamat SAS on file, 1 of them classified OAI (official action indicated).

Need more than this page shows? Ask about Vipamat SAS in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.